{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:24:31Z","timestamp":1790079871042,"version":"4.0.1"},"reference-count":133,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ecl.2016.09.012","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T02:32:14Z","timestamp":1481682734000},"page":"87-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Primary Hyperparathyroidism"],"prefix":"10.1016","volume":"46","author":[{"given":"Kyle A.","family":"Zanocco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ecl.2016.09.012_bib1","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/SLA.0b013e31824dad7d","article-title":"Surgery for primary hyperparathyroidism: are the consensus guidelines being followed?","volume":"255","author":"Yeh","year":"2012","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ecl.2016.09.012_bib3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jama.1990.03450050039024","article-title":"A\u00a0prospective study of hyperparathyroidism in individuals exposed to radiation in childhood","volume":"264","author":"Cohen","year":"1990","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib4","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.surg.2004.06.042","article-title":"The coming of age of radiation-induced hyperparathyroidism: evolving patterns of thyroid and parathyroid disease after head and neck irradiation","volume":"136","author":"Stephen","year":"2004","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib5","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.ijrobp.2008.06.1487","article-title":"Hyperparathyroidism after irradiation for childhood malignancy","volume":"73","author":"McMullen","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ecl.2016.09.012_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00268-011-1394-y","article-title":"Breast radiation correlates with side of parathyroid adenoma","volume":"36","author":"Woll","year":"2012","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.ecl.2016.09.012_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7326\/0003-4819-96-1-63","article-title":"Lithium-induced hyperparathyroidism: an alteration of the set-point","volume":"96","author":"Shen","year":"1982","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ecl.2016.09.012_bib8","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1210\/jcem-68-3-654","article-title":"Lithium Treatment Increases Intact and Midregion Parathyroid Hormone and Parathyroid Volume","volume":"68","author":"Mallette","year":"1989","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2016.09.012_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.beem.2010.01.003","article-title":"Clinical and molecular genetics of parathyroid neoplasms","volume":"24","author":"Sharretts","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2016.09.012_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200201000-00001","article-title":"Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds","volume":"81","author":"Simonds","year":"2002","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.ecl.2016.09.012_bib11","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0046-8177(86)80043-0","article-title":"Histologic parathyroid abnormalities in an autopsy series","volume":"17","author":"Akerstrom","year":"1986","journal-title":"Hum Pathol"},{"issue":"21","key":"10.1016\/j.ecl.2016.09.012_bib12","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM196605262742105","article-title":"The study of hyperparathyroidism at the Massachusetts General Hospital","volume":"274","author":"Cope","year":"1966","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib13","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1073\/pnas.95.4.1630","article-title":"Menin, the product of the MEN1 gene, is a nuclear protein","volume":"95","author":"Guru","year":"1998","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ng0897-375","article-title":"Somatic mutation of the MEN1 gene in parathyroid tumours","volume":"16","author":"Heppner","year":"1997","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ecl.2016.09.012_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/SLA.0b013e31824c5145","article-title":"Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype","volume":"255","author":"Pieterman","year":"2012","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ecl.2016.09.012_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/eje.0.1430047","article-title":"Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism","volume":"143","author":"Miedlich","year":"2000","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.ecl.2016.09.012_bib18","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/BF03345303","article-title":"Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics","volume":"27","author":"Scarpelli","year":"2004","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"19","key":"10.1016\/j.ecl.2016.09.012_bib19","first-page":"5553","article-title":"Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors","volume":"60","author":"Uchino","year":"2000","journal-title":"Cancer Res"},{"issue":"18","key":"10.1016\/j.ecl.2016.09.012_bib20","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism\u2013jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cytogfr.2005.05.010","article-title":"RET tyrosine kinase signaling in development and cancer","volume":"16","author":"Arighi","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the American Thyroid Association Guidelines Task Force on medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"issue":"19","key":"10.1016\/j.ecl.2016.09.012_bib24","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib25","first-page":"2041","article-title":"RET proto-oncogene point mutations in sporadic neuroendocrine tumors","volume":"81","author":"Komminoth","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2016.09.012_bib26","first-page":"449","article-title":"Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors","volume":"6","author":"Rosenberg","year":"1991","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib27","first-page":"412","article-title":"Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study","volume":"12","author":"Vasef","year":"1999","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.ecl.2016.09.012_bib28","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","article-title":"Mutations in the human Ca 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"75","author":"Pollak","year":"1993","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1365-2265.1999.00788.x","article-title":"Casting new light on the clinical spectrum of neonatal severe hyperparathyroidism","volume":"50","author":"Pearce","year":"1999","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib30","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jpedsurg.2009.08.005","article-title":"Surgical management of severe neonatal hyperparathyroidism: one center's experience","volume":"45","author":"Al-Shanafey","year":"2010","journal-title":"J\u00a0Pediatr Surg"},{"issue":"2","key":"10.1016\/j.ecl.2016.09.012_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/humu.20067","article-title":"CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia","volume":"24","author":"Pidasheva","year":"2004","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib32","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2265.2009.03557.x","article-title":"Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism","volume":"71","author":"Christensen","year":"2009","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2016.09.012_bib33","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1530\/EJE-15-1028","article-title":"Genetics in endocrinology: gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts","volume":"174","author":"Mayr","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib34","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1359\/jbmr.1999.14.6.878","article-title":"No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas","volume":"14","author":"Cetani","year":"1999","journal-title":"J\u00a0Bone Miner Res"},{"issue":"10","key":"10.1016\/j.ecl.2016.09.012_bib35","first-page":"3481","article-title":"Tumor-Specific Decreased Expression of Calcium Sensing Receptor Messenger Ribonucleic Acid in Sporadic Primary Hyperparathyroidism 1","volume":"82","author":"Farnebo","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2016.09.012_bib36","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2016.09.012_bib37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/M15-1232","article-title":"The Relationship of Parathyroidectomy and Bisphosphonates With Fracture Risk in Primary Hyperparathyroidism: An Observational Study","volume":"164","author":"Yeh","year":"2016","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.ecl.2016.09.012_bib38","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/endo.142.9.8356","article-title":"Catabolic effects of continuous human PTH (1\u201338) in\u00a0vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation","volume":"142","author":"Ma","year":"2001","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.ecl.2016.09.012_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J\u00a0Bone Miner Res"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib40","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jcem-70-4-930","article-title":"The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure","volume":"70","author":"Parisien","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2016.09.012_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bone.2007.03.020","article-title":"Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism","volume":"41","author":"Dempster","year":"2007","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.ecl.2016.09.012_bib42","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population-based study","volume":"14","author":"Khosla","year":"1999","journal-title":"J\u00a0Bone Miner Res"},{"issue":"7261","key":"10.1016\/j.ecl.2016.09.012_bib43","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/bmj.321.7261.598","article-title":"Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism","volume":"321","author":"Vestergaard","year":"2000","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.ecl.2016.09.012_bib44","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2008-2006","article-title":"Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism","volume":"94","author":"Vignali","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2016.09.012_bib45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2265.2009.03766.x","article-title":"Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS)","volume":"73","author":"Yu","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.ecl.2016.09.012_bib46","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1210\/jc.2005-1258","article-title":"In\u00a0vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography","volume":"90","author":"Boutroy","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2016.09.012_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2013.03.009","article-title":"New insights into the effects of primary hyperparathyroidism on the cortical and trabecular compartments of bone","volume":"55","author":"Vu","year":"2013","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.ecl.2016.09.012_bib48","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/jbmr.98","article-title":"Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: A case-control study using HR-pQCT","volume":"25","author":"Hansen","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"issue":"5","key":"10.1016\/j.ecl.2016.09.012_bib49","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/jbmr.1841","article-title":"Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women","volume":"28","author":"Stein","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"issue":"10","key":"10.1016\/j.ecl.2016.09.012_bib50","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2016.09.012_bib51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.amjmed.2014.09.030","article-title":"Hypercalcemic crisis: a clinical review","volume":"128","author":"Ahmad","year":"2015","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198001243020402","article-title":"Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community","volume":"302","author":"Heath","year":"1980","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ecl.2016.09.012_bib53","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2016.09.012_bib54","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-114-7-593","article-title":"NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement","volume":"114","year":"1991","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.ecl.2016.09.012_bib55","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1210\/jc.2002-021370","article-title":"Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century","volume":"87","author":"Bilezikian","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2016.09.012_bib56","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Third International Workshop on the Management of Asymptomatic Primary H. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2016.09.012_bib57","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0002-9343(90)90346-F","article-title":"Nephrolithiasis and bone involvement in primary hyperparathyroidism","volume":"89","author":"Silverberg","year":"1990","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.ecl.2016.09.012_bib58","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/jcem-53-3-536","article-title":"A\u00a0lack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism","volume":"53","author":"Pak","year":"1981","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2016.09.012_bib59","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2214\/AJR.07.3160","article-title":"Primary hyperparathyroidism: is there an increased prevalence of renal stone disease?","volume":"191","author":"Suh","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"10.1016\/j.ecl.2016.09.012_bib60","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1210\/jc.2009-0587","article-title":"Glomerular filtration rate and parathyroid hormone secretion in primary hyperparathyroidism","volume":"94","author":"Tassone","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2016.09.012_bib61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.2010.03958.x","article-title":"A\u00a0record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS)","volume":"75","author":"Yu","year":"2011","journal-title":"Clin Endocrinol"},{"issue":"8","key":"10.1016\/j.ecl.2016.09.012_bib62","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial","volume":"92","author":"Ambrogini","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib63","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1210\/jc.2014-3441","article-title":"Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism","volume":"100","author":"Lundstam","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2016.09.012_bib64","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism","volume":"89","author":"Rao","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2016.09.012_bib65","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1359\/jbmr.1998.13.8.1337","article-title":"The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study","volume":"13","author":"Sanders","year":"1998","journal-title":"J\u00a0Bone Miner Res"},{"issue":"10","key":"10.1016\/j.ecl.2016.09.012_bib66","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA surgery"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib67","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4103\/1305-7456.120657","article-title":"An unusual case of brown tumor of hyperparathyroidism associated with ectopic parathyroid adenoma","volume":"7","author":"Mohan","year":"2013","journal-title":"Eur J Dent"},{"issue":"3","key":"10.1016\/j.ecl.2016.09.012_bib68","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/archsurg.1922.01110120051002","article-title":"The generalized type of osteitis fibrosa cystica: von recklinghausen's disease","volume":"4","author":"Morton","year":"1922","journal-title":"Arch Surg"},{"issue":"5","key":"10.1016\/j.ecl.2016.09.012_bib69","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.0007-1323.2001.01775.x","article-title":"Unique clinical characteristics of primary hyperparathyroidism in India","volume":"88","author":"Mishra","year":"2001","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.ecl.2016.09.012_bib70","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1210\/jc.2012-2914","article-title":"The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center","volume":"98","author":"Zhao","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib71","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1590\/S0004-27302006000400011","article-title":"From mild to severe primary hyperparathyroidism: the Brazilian experience","volume":"50","author":"Bandeira","year":"2006","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib72","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Hypercalcemia associated with cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2016.09.012_bib73","series-title":"Harrison's principles of internal medicine","first-page":"313","article-title":"Hypercalcemia and hypocalcemia","author":"Khosla","year":"2015"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib74","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jc.2015-1619","article-title":"Hypertension, antihypertensive medications, and risk of incident primary hyperparathyroidism","volume":"100","author":"Vaidya","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2016.09.012_bib75","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1097\/HJH.0b013e32833bc5b4","article-title":"Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adults","volume":"28","author":"Zhao","year":"2010","journal-title":"J\u00a0Hypertens"},{"issue":"12","key":"10.1016\/j.ecl.2016.09.012_bib76","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jacc.2014.01.012","article-title":"Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"63","author":"Van Ballegooijen","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ecl.2016.09.012_bib77","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1507\/endocrj.EJ14-0004","article-title":"High serum parathyroid hormone and calcium are risk factors for hypertension in Japanese patients","volume":"61","author":"Yagi","year":"2014","journal-title":"Endocr J"},{"issue":"2","key":"10.1016\/j.ecl.2016.09.012_bib78","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1210\/jcem-55-2-303","article-title":"A\u00a0case-comparison study of hypertension and hyperparathyroidism","volume":"55","author":"Nainby-Luxmoore","year":"1982","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2016.09.012_bib79","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/10641960903254471","article-title":"Long-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure profile in primary hyperparathyroidism","volume":"32","author":"Feldstein","year":"2010","journal-title":"Clin Exp Hypertens"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib80","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.surg.2009.09.024","article-title":"Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism","volume":"146","author":"Heyliger","year":"2009","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib81","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.surg.2005.02.001","article-title":"Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism","volume":"137","author":"Nilsson","year":"2005","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.ecl.2016.09.012_bib82","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2265.1999.00651.x","article-title":"Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy","volume":"50","author":"Piovesan","year":"1999","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib83","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0039-6060(97)90216-6","article-title":"Survival after surgical treatment for primary hyperparathyroidism","volume":"122","author":"Soreide","year":"1997","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.ecl.2016.09.012_bib84","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(97)00270-2","article-title":"Survival after the diagnosis of hyperparathyroidism: a population-based study","volume":"104","author":"Wermers","year":"1998","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib85","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/BF01670531","article-title":"Premature death in patients operated on for primary hyperparathyroidism","volume":"14","author":"Hedback","year":"1990","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.ecl.2016.09.012_bib86","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00268-003-7046-0","article-title":"Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977-1993 in Denmark","volume":"28","author":"Ogard","year":"2004","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.ecl.2016.09.012_bib87","first-page":"1","article-title":"Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979","volume":"102","author":"Palmer","year":"1987","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.ecl.2016.09.012_bib88","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00268-002-6541-z","article-title":"Cardiovascular events before and after surgery for primary hyperparathyroidism","volume":"27","author":"Vestergaard","year":"2003","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib89","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/01.sla.0000120072.85692.a7","article-title":"The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited?","volume":"239","author":"Eigelberger","year":"2004","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib90","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.surg.2005.08.033","article-title":"Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism","volume":"138","author":"Roman","year":"2005","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.ecl.2016.09.012_bib91","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2265.2011.04197.x","article-title":"The effect of parathyroidectomy on neuropsychological symptoms and biochemical parameters in patients with asymptomatic primary hyperparathyroidism","volume":"76","author":"Kahal","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.ecl.2016.09.012_bib92","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.surg.2015.03.054","article-title":"Improvement in patient-reported physical and mental health after parathyroidectomy for primary hyperparathyroidism","volume":"158","author":"Zanocco","year":"2015","journal-title":"Surgery"},{"issue":"S2","key":"10.1016\/j.ecl.2016.09.012_bib93","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1002\/jbmr.5650061413","article-title":"Differential diagnosis of hypercalcemia","volume":"6","author":"Lafferty","year":"1991","journal-title":"J\u00a0Bone Miner Res"},{"issue":"3","key":"10.1016\/j.ecl.2016.09.012_bib94","doi-asserted-by":"crossref","first-page":"468","DOI":"10.7326\/0003-4819-63-3-468","article-title":"Hyperparathyroidism detected by routine serum calcium analysis: prevalence in a clinic population","volume":"63","author":"Boonstra","year":"1965","journal-title":"Ann Intern Med"},{"issue":"1\u20136","key":"10.1016\/j.ecl.2016.09.012_bib95","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.0954-6820.1976.tb08208.x","article-title":"Prevalence of hypercalcaemia in a health screening in Stockholm","volume":"200","author":"Christensson","year":"1976","journal-title":"Acta Med Scand"},{"issue":"5","key":"10.1016\/j.ecl.2016.09.012_bib96","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2265.2008.03259.x","article-title":"Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods","volume":"69","author":"Christensen","year":"2008","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2016.09.012_bib97","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jocd.2012.12.001","article-title":"Normocalcemic primary hyperparathyroidism","volume":"16","author":"Cusano","year":"2013","journal-title":"J\u00a0Clin Densitom"},{"issue":"1","key":"10.1016\/j.ecl.2016.09.012_bib98","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hed.22908","article-title":"Parathyroid cancer: outcome analysis of 16 patients treated at the princess Margaret hospital","volume":"35","author":"Erovic","year":"2013","journal-title":"Head Neck"},{"issue":"12","key":"10.1016\/j.ecl.2016.09.012_bib99","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1210\/jc.2011-1571","article-title":"Parathyroid carcinoma: a 43-year outcome and survival analysis","volume":"96","author":"Harari","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2016.09.012_bib100","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.amjsurg.2010.09.025","article-title":"Incidence and prognosis of parathyroid gland carcinoma: a population-based study in The Netherlands estimating the preoperative diagnosis","volume":"202","author":"Schaapveld","year":"2011","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.ecl.2016.09.012_bib101","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11864-011-0171-3","article-title":"Parathyroid carcinoma: update and guidelines for management","volume":"13","author":"Wei","year":"2012","journal-title":"Curr Treat Options Oncol"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib102","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s002230010086","article-title":"Calcium-induced natriuresis: physiologic and clinical implications","volume":"66","author":"Adami","year":"2000","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1016\/j.ecl.2016.09.012_bib103","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1245\/s10434-011-1870-5","article-title":"A\u00a0meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism","volume":"19","author":"Cheung","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ecl.2016.09.012_bib104","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1245\/s10434-014-4331-0","article-title":"Dynamic Parathyroid Computed tomography (4DCT) facilitates reoperative parathyroidectomy and enables cure of missed hyperplasia","volume":"22","author":"Cham","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.ecl.2016.09.012_bib105","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jc.2014-2000","article-title":"The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop","volume":"99","author":"Udelsman","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib106","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archsurg.141.4.401","article-title":"Minimally invasive parathyroidectomy using cervical block: reasons for conversion to general anesthesia","volume":"141","author":"Carling","year":"2006","journal-title":"Arch Surg"},{"issue":"12","key":"10.1016\/j.ecl.2016.09.012_bib107","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00268-004-7600-4","article-title":"Open minimally invasive parathyroid surgery","volume":"28","author":"Udelsman","year":"2004","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib108","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.otc.2004.02.020","article-title":"Prevention and management of complications in parathyroid surgery","volume":"37","author":"Carty","year":"2004","journal-title":"Otolaryngol Clin North Am"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib109","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.surg.2011.09.025","article-title":"Population-level predictors of persistent hyperparathyroidism","volume":"150","author":"Yeh","year":"2011","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib110","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.surg.2007.09.003","article-title":"Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery","volume":"142","author":"Stavrakis","year":"2007","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib111","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/SLA.0000000000000812","article-title":"Trends in the frequency and quality of parathyroid surgery: analysis of 17,082 cases over 10 years","volume":"261","author":"Abdulla","year":"2015","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib112","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/qjmed\/hcq261","article-title":"The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and audit research study","volume":"104","author":"Yu","year":"2011","journal-title":"QJM"},{"issue":"8","key":"10.1016\/j.ecl.2016.09.012_bib113","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1210\/jc.2011-0569","article-title":"Nephrolithiasis and renal calcifications\u00a0in primary hyperparathyroidism","volume":"96","author":"Rejnmark","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2016.09.012_bib114","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1210\/jc.2014-1379","article-title":"Renal impairment as a surgical indication in primary hyperparathyroidism: do the data support this recommendation?","volume":"99","author":"Hendrickson","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2016.09.012_bib115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/cen.12206","article-title":"What predicts adverse outcomes in untreated primary hyperparathyroidism? The parathyroid epidemiology and audit research study (PEARS)","volume":"79","author":"Yu","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib116","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1365-2265.2011.04201.x","article-title":"Should \u2018mild primary hyperparathyroidism\u2019 be reclassified as \u2018insidious\u2019: is it time to reconsider?","volume":"75","author":"Macfarlane","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.ecl.2016.09.012_bib117","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.surg.2004.05.044","article-title":"Mortality in sporadic primary hyperparathyroidism: nationwide cohort study of multiple parathyroid gland disease","volume":"136","author":"Nilsson","year":"2004","journal-title":"Surgery"},{"issue":"7368","key":"10.1016\/j.ecl.2016.09.012_bib118","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/bmj.325.7368.807","article-title":"Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study","volume":"325","author":"Mollerup","year":"2002","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.ecl.2016.09.012_bib119","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1210\/jc.2015-2132","article-title":"Parathyroidectomy halts the deterioration of renal function in primary hyperparathyroidism","volume":"100","author":"Tassone","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib120","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.surg.2009.10.021","article-title":"The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study","volume":"146","author":"Pasieka","year":"2009","journal-title":"Surgery"},{"issue":"12","key":"10.1016\/j.ecl.2016.09.012_bib121","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2009-1472","article-title":"Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study","volume":"94","author":"Peacock","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2016.09.012_bib122","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1210\/jc.2009-2384","article-title":"Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis","volume":"95","author":"Sankaran","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7444","key":"10.1016\/j.ecl.2016.09.012_bib123","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/bmj.328.7444.849","article-title":"Minimally invasive parathyroidectomy","volume":"328","author":"Palazzo","year":"2004","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib124","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0039-6060(99)70052-8","article-title":"American Association of Endocrine Surgeons. Presidential address: chasin' hormones","volume":"126","author":"Irvin","year":"1999","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.ecl.2016.09.012_bib125","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000658-200211000-00001","article-title":"Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial","volume":"236","author":"Bergenfelz","year":"2002","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ecl.2016.09.012_bib126","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jamcollsurg.2008.01.066","article-title":"How does the operative strategy for primary hyperparathyroidism impact the findings and cure rate? A comparison of 800 parathyroidectomies","volume":"207","author":"McGill","year":"2008","journal-title":"J\u00a0Am Coll Surg"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib127","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.surg.2012.08.022","article-title":"Is minimally invasive parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1,000 cases","volume":"152","author":"Schneider","year":"2012","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.ecl.2016.09.012_bib128","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jamcollsurg.2011.12.007","article-title":"Abandoning unilateral parathyroidectomy: why we reversed our position after 15,000 parathyroid operations","volume":"214","author":"Norman","year":"2012","journal-title":"J\u00a0Am Coll Surg"},{"issue":"3","key":"10.1016\/j.ecl.2016.09.012_bib129","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/SLA.0b013e3181859f71","article-title":"Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases","volume":"248","author":"Siperstein","year":"2008","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.ecl.2016.09.012_bib130","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1007\/s00268-015-3043-3","article-title":"What should we tell our patients? Lifetime guarantee or is it 5- to 10-year warranty on a parathyroidectomy for primary hyperparathyroidism?","volume":"39","author":"Pasieka","year":"2015","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.ecl.2016.09.012_bib131","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4158\/EP.9.6.494","article-title":"Clinical management of primary hyperparathyroidism and thresholds for surgical referral: a national study examining concordance between practice patterns and consensus panel recommendations","volume":"9","author":"Mahadevia","year":"2003","journal-title":"Endocr Pract"},{"issue":"8","key":"10.1016\/j.ecl.2016.09.012_bib132","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0002-9343(02)01306-2","article-title":"Age as a criterion for surgery in primary hyperparathyroidism","volume":"113","author":"Silverberg","year":"2002","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.ecl.2016.09.012_bib133","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N\u00a0Engl J Med"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852916301050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852916301050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:42:48Z","timestamp":1760175768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852916301050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":133,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0889852916301050"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2016.09.012","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2016.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}